Resources

Results 1126 - 1150 of 1225

MTaPS Supporting the Global Health Security Agenda Fact Sheet

USAID MTaPS supports the Global Health Security Agenda (GHSA), whose purpose is to help build countries’ capacity to protect themselves from infectious disease threats and to raise global health security as a national and worldwide priority. The GHSA has 11 action packages, including one to combat antimicrobial resistance (AMR).

MTaPS General Information Fact Sheet

Funded by USAID and led by Management Sciences for Health and its consortium of partners, the goal of the five-year Medicines, Technologies, and Pharmaceutical Services (MTaPS) program (2018–2023) is to help low- and middle- income countries strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essentia

MTaPS Governance Fact Sheet

Attaining the goals of universal health coverage requires clear policies, robust legislation, and sound management practices supported by good governance. This premise is relevant to pharmaceutical systems, which are particularly vulnerable to corruption due to the economic value of medicines and the multiplicity of stakeholders.

MTaPS Malaria Fact Sheet

WHO’s Global Technical Strategy (GTS) for Malaria 2016–2030 aims to reduce global malaria incidence and deaths by at least 90% by 2030. To achieve these targets, high malaria burden countries need strong national pharmaceutical systems that can support the effective implementation of key malaria interventions.

MTaPS Tuberculosis Fact Sheet

In recent years, significant donor and global TB community support has led to encouraging developments, giving low- and middle-income countries better diagnostic, prevention, and treatment tools to increase case detection and improve outcomes.

Institutionalizing Infection Prevention and Control in a TB and Lung Disease Hospital in Bangladesh

TB infection prevention and control (IPC) is an important strategy to prevent disease transmission—it is a combination of measures to minimize the risk of transmission from a TB case to other patients, health care providers, and the wider population.

Patient enrollment in shorter treatment regimen under national DR-TB Program: Lessons from Bangladesh

Bangladesh is one of the world’s high MDR-TB burden countries. According to the WHO, the MDR-TB burden is 1.6% among new cases and 29% among retreatment cases. The longer duration of MDR-TB treatment regimens and the toxicity of certain agents discourage many patients from completing treatment.

Institutionalizing a prefabricated Bio-Safety Level-3 laboratory: Lessons from Bangladesh

In collaboration with the National TB Control Program (NTP) in Bangladesh, the USAID-funded Challenge TB established a high-quality Bio-Safety Level-3 Laboratory (BSL-3 lab) in Sylhet to accelerate TB and DR-TB diagnosis and treatment in the northeast region of the country. The BSL-3 lab, the highest level of safety of its type in Bangladesh, provides rapid and quality services.

Associations between Practices and Behaviors at the Health Facility Level and Supply Chain Management for Antiretrovirals: Evidence from Cameroon, Namibia, and Swaziland

Using antiretrovirals (ARVs) as tracer products, we identified the following key practices that may affect supply chain management at the facility level: order verification, actions taken when stock is received, changes in prescription and dispensing due to ARV stock-out, actions to ensure patient adherence, and communication with other affiliated facilities and higher-level supply chain management. We propose a set of indicators to measure these practices.

MTaPS Strengthening Pharmaceutical Supply Chain Systems Fact Sheet

Ensuring the uninterrupted availability of quality-assured medicines and health technologies from the manufacturer to end users is the ultimate goal of pharmaceutical supply chain systems. However, strategies to strengthen key supply chain components are inadequate in many low- and middle-income countries (LMICs), and systems cannot effectively manage local and global health program demands.

MTaPS Enhancing the Availability and Use of Information for Decision Making Fact Sheet

Pharmaceutical systems and the health system in general in many low- and middle-income countries suffer from poor data availability and accessibility. Typically, data are manually collected at service delivery points and then sent to the district, regional, or Ministry level for processing and storage with the hope that they will be captured electronically and analyzed.

MTaPS HIV and AIDS Fact Sheet

An AIDS-free world requires resilient and sustainable pharmaceutical systems that ensure universal access to the best available diagnostic, preventive, and treatment tools.

MTaPS Supporting Pharmaceutical Regulatory Systems Fact Sheet

Weaknesses in pharmaceutical regulatory systems contribute to limited access to quality-assured, safe, and efficacious life-saving essential medicines, including those for malaria; HIV/AIDS; and reproductive, maternal, and childhood diseases, and to the disruption of health service delivery, thereby preventing achievement of better health outcomes.

MTaPS Pharmaceutical Financing Fact Sheet

USAID supports strategies to improve pharmaceutical-sector financing, including resource mobilization, allocation, and use.

MTaPS Institutional and HR Capacity Fact Sheet

Following USAID’s Journey to Self-Reliance framework and the agency’s health system and disease-specific strategies, MTaPS strengthens country human resources and institutions to: develop sustainable, high-impact country capacity for transparent, accountable pharmaceutical systems-related law, policy, planning, leadership, and management; improve countries’ capacity to collect, a

MTaPS Improving the Quality of Pharmaceutical Services to Enhance Treatment Outcomes Fact Sheet

USAID MTaPS applies systems-based approaches using proven tools, interventions, and quality improvement methodologies to strengthen in-country capacity and enhance patient-centered pharmaceutical care. In doing so, MTaPS embeds the culture of quality of care emphasized by the Sustainable Development Goals, the World Health Organization, and other global and national bodies.

Combating Antimicrobial Resistance with Stronger Health Systems

Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats —one that could erode gains against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. While AMR has emerged as a critical issue at the global level, current efforts to address AMR are insufficient to curb its spread.

Statement of revenues, program expenses, and changes in fund balance, fiscal year 2018

Year Ended June 30, 2018, drawn from audited financial statements.

Annual report 2018: Getting to the heart of health systems

Since 1971, MSH has worked in more than 150 countries to strengthen health systems and help our partners consistently deliver effective, affordable, and available medicines and services. We lead by supporting and educating, helping people build on what they already know to ultimately take charge of their own development—and their own health.

Intensive support for improved TB case detection: Lessons from Ethiopian public hospitals

The USAID-funded Challenge TB project collaborated with the Ethiopian National TB Control Program (NTP) and regional health bureaus to integrate TB screening into all health service outlets across the country. The intensive support included mentorship of hospital staff by zonal and regional teams, routine check-ins, on-site capacity building, and close follow-up.

Introduction of second line probe assay in laboratory system in Ethiopia

Previously, Ethiopia used conventional methods for mycobacteria culture and drug susceptibility testing, which take 4-12 weeks to get results and require sequential procedures for the diagnosis. The recently introduced second-line probe assay (SL-LPA) delivers results in just 24-48 hours, a vast improvement over the conventional method.

Introduction of point of care testing for multidrug-resistant tuberculosis patients

The Ethiopian National TB Program (NTP) has made important contributions to the decentralization of multidrug-resistant (MDR) treatment and follow-up sites across the country.

Strong partnership for improved TB and HIV indicators: IPT uptake and completion

The dual burden of TB and HIV infection has prompted global attention as well as WHO policies and guidelines.

Telephone monitoring to improve IPT uptake: Experience from Tigray, Ethiopia

Ethiopia is among high TB-HIV burden countries and uptake of live-saving treatment among people living with HIV/AIDS (PLWHA) has remained low at the national level.

Developing a health care workforce requirement and recruitment plan in Tanzania

The Technical Support Services Project (TSSP) worked with the Tanzania Ministry of Health, Community Development, Gender, Elderly, and Children (MoHCDGEC) to analyze data to project future health care employment needs, including current and future vacancies, and create a five-year recruitment and staffing plan.